Vanderbilt-Ingram Cancer Center

Vanderbilt-Ingram website >

September 29, 2020

VICC receives ‘exceptional’ score with renewal as an NCI-Designated Comprehensive Cancer Center

Vanderbilt-Ingram Cancer Center (VICC) received an overall “exceptional” score for its research impact and excellence in patient care. This achievement merits renewed funding from the National Cancer Institute (NCI) and places it once again in a top group of NCI Comprehensive Cancer Centers.

By Tom Wilemon
August 27, 2020

Leverett named chief of Section of Breast Imaging

Reagan Leverett, MD, MS, associate professor of Radiology and Radiological Sciences and medical director of Vanderbilt Breast Imaging Services, has been named chief of the Section of Breast Imaging, a position she previously held on an interim basis.

By Kelsey Herbers
When it opens Aug. 31, Vanderbilt-Ingram Cancer Center at Wilson County Hospital will be a full-fledged multidisciplinary facility equipped with the latest cancer treatment technologies.
August 27, 2020

Vanderbilt-Ingram opens cancer center in Wilson County

Vanderbilt-Ingram Cancer Center at Wilson County is slated to open Aug. 31 with a full array of highly specialized services, including diagnostic assessments, medical oncology and radiation oncology.

By Tom Wilemon
August 26, 2020

Chang named Vanderbilt-Ingram Cancer Center chief surgical officer

Sam Chang, MD, MBA, has been named chief surgical officer at Vanderbilt-Ingram Cancer Center (VICC), a new leadership position responsible for advancing excellence in surgical care in cancer patients, expanding service locations, maximizing resource efficiencies and maintaining high-quality standards among other duties.

By Tom Wilemon
August 13, 2020

Acupressure studied to treat neonatal opioid withdrawal

Researchers from Vanderbilt University Medical Center recently completed a study to create a standardized protocol for using acupressure to treat newborns with opioid withdrawal syndrome.

By Kelsey Herbers
August 10, 2020

A step toward cancer prevention

A computational technique that combines the effect of multiple genomic variants has the potential to identify high-risk individuals for cancer prevention.

By Bill Snyder
July 30, 2020

Iams honored by National Comprehensive Cancer Network

Wade Iams, MD, MSCI, assistant professor of Medicine, is the recipient of a National Comprehensive Cancer Network Foundation Young Investigator Award.
By Tom Wilemon
July 2, 2020

Friedman named associate director for Community Science and Health Outcomes at Vanderbilt-Ingram Cancer Center

Debra Friedman, MD, MS, E. Bronson Ingram Chair of Pediatric Oncology, is expanding her leadership role in improving cancer outcomes both within and beyond the Vanderbilt-Ingram Cancer Center (VICC) catchment area. She has been named associate director of Community Science and Health Outcomes.
By Tom Wilemon
June 24, 2020

Study shows better option for treatment of inoperable anal cancer

People with inoperable anal cancer treated with carboplatin-paclitaxel had fewer complications and lived longer than those who received another chemotherapy that has been more often administered.
By Tom Wilemon
June 18, 2020

Cortez named to VICC research leadership role

David Cortez, PhD, has been named associate director for Basic Science Research at Vanderbilt-Ingram Cancer Center (VICC).
By Tom Wilemon
May 21, 2020

State cancer plan has robust input and commitment from Vanderbilt-Ingram Cancer Center

More than a dozen representatives of Vanderbilt University Medical Center helped plan and made a commitment to help carry out the strategy for how Tennessee will prevent cancer and minimize its burden on state residents.
By Tom Wilemon
April 23, 2020

Polygenic scores identify those at high cancer risk

A team of Vanderbilt researchers constructed polygenic risk scores (PRS) based on genomic variants associated with eight common cancers and concluded they could potentially be used for personalized risk assessments.
By Tom Wilemon
March 5, 2020

One-two punch for cancer

A drug combination effectively killed aggressive blood cancers in cell and animal models; now it’s being tested in patients.
By Sanjay Mishra
1 … 16 17 18 19 20 … 26